Erschienen in:
15.07.2015 | What's New in Intensive Care
Biomarkers of ARDS: what’s new?
verfasst von:
Lorraine B. Ware, Carolyn S. Calfee
Erschienen in:
Intensive Care Medicine
|
Ausgabe 5/2016
Einloggen, um Zugang zu erhalten
Excerpt
Despite hundreds of studies of biomarkers in the acute respiratory distress syndrome (ARDS), there are no biomarkers of ARDS in use in clinical practice [
1]. A recent meta-analysis highlights some of the limitations of current studies: small sample sizes, inadequate and inconsistent controls, and lack of large validation studies for many biomarkers [
2]. Nevertheless, recent progress in several areas of biomarker research, including advances in the development of point-of-care testing technologies, has the potential to transform the application of biomarkers to clinical ARDS and may soon lead to the use of biomarkers at the bedside for diagnosis, risk stratification, and molecular phenotyping. …